ImmunoPrecise Antibodies (IPA)
(Delayed Data from NSDQ)
$1.15 USD
-0.02 (-1.71%)
Updated May 23, 2024 10:17 AM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Brokerage Reports
ImmunoPrecise Antibodies Ltd. [IPA]
Reports for Purchase
Showing records 1 - 8 ( 8 total )
Company: ImmunoPrecise Antibodies Ltd.
Industry: Medical Info Systems
Revenue Growth Momentum Persists; Expanding AI Capabilities; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: ImmunoPrecise Antibodies Ltd.
Industry: Medical Info Systems
Key Takeways From Our AI-Based Drug Discovery and Development Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: ImmunoPrecise Antibodies Ltd.
Industry: Medical Info Systems
Maintaining Fiscal Prudence While Executing for Growth; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: ImmunoPrecise Antibodies Ltd.
Industry: Medical Info Systems
Focus Continues on Synergistic Products and Services; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: ImmunoPrecise Antibodies Ltd.
Industry: Medical Info Systems
Company: ImmunoPrecise Antibodies Ltd.
Industry: Medical Info Systems
BioStrand and Talem to Deliver Long-Term Growth; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: ImmunoPrecise Antibodies Ltd.
Industry: Medical Info Systems
Project Sales Continue to Deliver; Meaningful BioStrand Contributions Expected in 2023; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: ImmunoPrecise Antibodies Ltd.
Industry: Medical Info Systems
CRO With Cutting-Edge Antibody Discovery Technologies; Initiate With Buy and a $9 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
|